Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Apr-24 6:07 PM View:  | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 04-Apr-24 | Planned Option Sale | 42,500 | $15.55 | $660,839.00 | (83%) 51.4K to 8.89K | |
| 08-Apr-24 6:07 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 04-Apr-24 | Sale (Planned) | 8,895 | $15.55 | $138,310.00 | (100%) 8.89K to 0 | |
| 08-Apr-24 6:07 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 04-Apr-24 | Option Exercise | 42,500 | $4.82 | $204,850.00 | 478% 8.89K to 51.4K | |
| 08-Mar-24 4:14 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 06-Mar-24 | Option Exercise | 19,625 | $10.90 | $213,875.00 | 221% 8.89K to 28.52K | |
| 08-Mar-24 4:14 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 06-Mar-24 | Planned Option Sale | 19,625 | $21.50 | $421,938.00 | (69%) 28.52K to 8.89K | |
| 06-Mar-24 4:20 PM View: | Risser Eric Blasius Chief Operating Officer | MacRogenics Inc (MGNX) | 04-Mar-24 | Sale (Planned) | 26,159 | $19.76 | $517,029.00 | (40%) 65.06K to 38.9K | |
| 06-Mar-24 4:19 PM View: | Spitznagel Thomas Sr VP, Technical Ops | MacRogenics Inc (MGNX) | 04-Mar-24 | Option Exercise | 10,000 | $11.50 | $115,000.00 | 120% 8.32K to 18.32K | |
| 06-Mar-24 4:18 PM View: | Karrels James SVP, CFO and Secretary | MacRogenics Inc (MGNX) | 04-Mar-24 | Private Sale (Planned) | 30,000 | $20.50 | $615,000.00 | (15%) 201.45K to 171.45K | |
| 06-Mar-24 4:20 PM View: | Risser Eric Blasius Chief Operating Officer | MacRogenics Inc (MGNX) | 04-Mar-24 | Option Exercise | 15,000 | $10.15 | $152,250.00 | 23% 65.06K to 80.06K | |
| 06-Mar-24 4:19 PM View: | Spitznagel Thomas Sr VP, Technical Ops | MacRogenics Inc (MGNX) | 04-Mar-24 | Planned Option Sale | 10,000 | $20.00 | $200,000.00 | (55%) 18.32K to 8.32K | |
| 06-Mar-24 4:20 PM View: | Risser Eric Blasius Chief Operating Officer | MacRogenics Inc (MGNX) | 04-Mar-24 | Planned Option Sale | 15,000 | $19.76 | $296,473.00 | (19%) 80.06K to 65.06K | |
| 28-Feb-24 4:20 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 26-Feb-24 | Private Sale (Planned) | 16,124 | $17.22 | $277,655.00 | (64%) 25.02K to 8.89K | |
| 26-Feb-24 4:26 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 22-Feb-24 | Option Exercise | 28,125 | -- | -- | 34% 82.13K to 110.26K | |
| 26-Feb-24 4:27 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 22-Feb-24 | Payment of Exercise | 10,126 | $17.11 | $173,256.00 | (29%) 35.15K to 25.02K | |
| 26-Feb-24 4:27 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 22-Feb-24 | Option Exercise | 26,250 | -- | -- | 295% 8.89K to 35.15K | |
| 26-Feb-24 4:26 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 22-Feb-24 | Payment of Exercise | 9,366 | $17.11 | $160,252.00 | (8%) 110.26K to 100.89K | |
| 20-Feb-24 6:03 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 15-Feb-24 | Payment of Exercise | 5,871 | $17.40 | $102,155.00 | (7%) 88.0K to 82.13K | |
| 20-Feb-24 6:04 PM View: | Koenig Scott President and CEO Director | MacRogenics Inc (MGNX) | 15-Feb-24 | Option Exercise | 42,341 | -- | -- | 4% 1.05M to 1.09M | |
| 20-Feb-24 6:04 PM View: | Cilinski Lynn VP, Controller and Treasurer | MacRogenics Inc (MGNX) | 15-Feb-24 | Option Exercise | 6,668 | -- | -- | 347% 1.92K to 8.59K | |
| 20-Feb-24 6:03 PM View: | Spitznagel Thomas Sr VP, Technical Ops | MacRogenics Inc (MGNX) | 15-Feb-24 | Payment of Exercise | 5,020 | $17.40 | $87,348.00 | (38%) 13.34K to 8.32K | |
| 20-Feb-24 6:04 PM View: | Karrels James SVP, CFO and Secretary | MacRogenics Inc (MGNX) | 15-Feb-24 | Payment of Exercise | 5,327 | $17.40 | $92,689.80 | (1%) 413.56K to 408.23K | |
| 20-Feb-24 6:41 PM View: | Eck Stephen L. Chief Medical Officer | MacRogenics Inc (MGNX) | 15-Feb-24 | Payment of Exercise | 6,872 | $17.40 | $119,573.00 | (41%) 16.67K to 9.8K | |
| 20-Feb-24 6:04 PM View: | Risser Eric Blasius Chief Operating Officer | MacRogenics Inc (MGNX) | 15-Feb-24 | Payment of Exercise | 5,879 | $17.40 | $102,295.00 | (8%) 70.94K to 65.06K | |
| 20-Feb-24 6:03 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 15-Feb-24 | Option Exercise | 16,670 | -- | -- | 23% 71.33K to 88.0K | |
| 20-Feb-24 6:03 PM View: | Spitznagel Thomas Sr VP, Technical Ops | MacRogenics Inc (MGNX) | 15-Feb-24 | Option Exercise | 13,336 | -- | -- | 100% 0 to 13.34K | |
| 20-Feb-24 6:04 PM View: | Karrels James SVP, CFO and Secretary | MacRogenics Inc (MGNX) | 15-Feb-24 | Option Exercise | 15,003 | -- | -- | 4% 398.56K to 413.56K | |
| 20-Feb-24 6:05 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 15-Feb-24 | Payment of Exercise | 4,441 | $17.40 | $77,273.40 | (33%) 13.34K to 8.89K | |
| 20-Feb-24 6:04 PM View: | Koenig Scott President and CEO Director | MacRogenics Inc (MGNX) | 15-Feb-24 | Payment of Exercise | 14,349 | $17.40 | $249,673.00 | (1%) 1.09M to 1.08M | |
| 20-Feb-24 6:05 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 15-Feb-24 | Option Exercise | 13,336 | -- | -- | 100% 0 to 13.34K | |
| 20-Feb-24 6:41 PM View: | Eck Stephen L. Chief Medical Officer | MacRogenics Inc (MGNX) | 15-Feb-24 | Option Exercise | 16,670 | -- | -- | 100% 0 to 16.67K | |
| 20-Feb-24 6:04 PM View: | Cilinski Lynn VP, Controller and Treasurer | MacRogenics Inc (MGNX) | 15-Feb-24 | Payment of Exercise | 2,378 | $17.40 | $41,377.20 | (28%) 8.59K to 6.21K | |
| 20-Feb-24 6:04 PM View: | Risser Eric Blasius Chief Operating Officer | MacRogenics Inc (MGNX) | 15-Feb-24 | Option Exercise | 16,670 | -- | -- | 31% 54.27K to 70.94K | |
| 07-Feb-24 4:19 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 07-Feb-24 | Private Sale (Planned) | 3,334 | $18.00 | $60,012.00 | (4%) 74.67K to 71.33K | |
| 07-Feb-24 4:17 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 05-Feb-24 | Option Exercise | 76,251 | $11.11 | $847,355.00 | 100% 0 to 76.25K | |
| 07-Feb-24 4:17 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 05-Feb-24 | Planned Option Sale | 76,251 | $16.50 | $1,258,140.00 | (100%) 76.25K to 0 | |
| 02-Feb-24 4:21 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 01-Feb-24 | Market Sale (Planned) | 13,316 | $15.00 | $199,740.00 | (15%) 87.98K to 74.67K | 1% |
| 22-Jan-24 4:57 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 19-Jan-24 | Sale (Planned) | 13,316 | $12.00 | $159,792.00 | (13%) 101.3K to 87.98K | |
| 21-Dec-23 4:12 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 20-Dec-23 | Sale (Planned) | 18,880 | $10.08 | $190,310.00 | (16%) 120.18K to 101.3K | |
| 04-Oct-23 3:31 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 02-Oct-23 | Private Purchase | 150,000 | $4.46 | $669,585.00 | 2% 9.78M to 9.93M | |
| 11-Sep-23 3:39 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 07-Sep-23 | Private Purchase | 200,000 | $5.26 | $1,052,840.00 | 2% 9.58M to 9.78M | |
| 01-Sep-23 4:06 PM View: | Hurwitz Edward Director | MacRogenics Inc (MGNX) | 30-Aug-23 | Private Purchase | 15,000 | $4.91 | $73,650.00 | 83% 18.07K to 33.07K | |
| 14-Mar-23 4:22 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 10-Mar-23 | Sale (Planned) | 5,372 | $6.03 | $32,393.20 | (100%) 5.37K to 0 | |
| 24-Feb-23 4:35 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 22-Feb-23 | Option Exercise | 8,750 | -- | -- | 100% 0 to 8.75K | |
| 24-Feb-23 4:34 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 22-Feb-23 | Option Exercise | 9,375 | -- | -- | 8% 114.42K to 123.8K | |
| 24-Feb-23 4:34 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 22-Feb-23 | Payment of Exercise | 3,619 | $6.55 | $23,704.50 | (3%) 123.8K to 120.18K | |
| 24-Feb-23 4:35 PM View: | Peters Jeffrey Stuart Senior VP and General Counsel | MacRogenics Inc (MGNX) | 22-Feb-23 | Payment of Exercise | 3,378 | $6.55 | $22,125.90 | (39%) 8.75K to 5.37K | |
| 16-Feb-23 12:37 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 14-Feb-23 | Private Purchase | 500,000 | $5.07 | $2,532,600.00 | 6% 9.08M to 9.58M | |
| 23-Jan-23 4:21 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 19-Jan-23 | Private Purchase | 150,000 | $5.30 | $794,925.00 | 2% 8.93M to 9.08M | |
| 28-Dec-22 11:03 AM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 27-Dec-22 | Purchase | 200,000 | $5.61 | $1,121,800.00 | 2% 8.73M to 8.93M | |
| 28-Dec-22 11:03 AM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 23-Dec-22 | Private Purchase | 200,000 | $5.88 | $1,176,800.00 | 2% 8.53M to 8.73M |
